It is important for patients and prescribers to understand that majority of cannabis medications are unapproved medicines, which are only available through specialised access schemes provided by the Therapeutic Goods Administration.
Guidance documents and clinical trial information are available for patients and practitioners for particular medical conditions through the Therapeutic Goods Administration website:
Many clinical trials have been conducted on medicinal cannabis products and notable research institutes, such as the Lambert Institute, are undertaking research on the effects that cannabinoids have on a wide range of conditions. For more information see the links below:
Multiple Sclerosis Randomised Controlled Trials and Other Studies
Pain Randomised Controlled Trials and Other Studies
Epilepsy Randomised Controlled Trials and Other Studies
Nausea and Vomiting Randomised Controlled Trials and Other Studies
Palliation Randomised Controlled Trials and Other Studies